These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 13496)

  • 1. Haemodynamic effects of different beta blockers in angina pectoris.
    Aström H; Jonsson B
    Scott Med J; 1977 Jan; 22(1):64-8. PubMed ID: 13496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.
    Aström H; Vallin H
    Br Heart J; 1974 Dec; 36(12):1194-1200. PubMed ID: 4155316
    [No Abstract]   [Full Text] [Related]  

  • 3. Mode of action of beta blockers in angina pectoris.
    Ablad B; Carlsson E; Ek L; Johnsson G
    Scott Med J; 1977 Jan; 22(1):52-63. PubMed ID: 13495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic effects of bufuralol: a beta-adrenoceptor blocking drug with vasodilatory effects.
    Pfisterer M; Burckhardt D; Bühler FR; Burkart F
    J Cardiovasc Pharmacol; 1984; 6(3):417-22. PubMed ID: 6202966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic receptor blocking drugs in angina pectoris.
    Prichard BN
    Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical, electrocardiographic, and haemodynamic effects of digitalis (ouabain) in angina pectoris.
    Sharma B; Majid PA; Meeran MK; Whitaker W; Taylor SH
    Br Heart J; 1972 Jun; 34(6):631-7. PubMed ID: 4402698
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical, electrocardiographic, and hemodynamic effects of ICI 89,406, a new cardioselective beta-adrenoceptor antagonist with intrinsic sympathomimetic activity, in patients with angina pectoris.
    Majid PA; Schreuder JE; de Feyter PJ; Roos JP
    J Cardiovasc Pharmacol; 1980; 2(4):435-44. PubMed ID: 6156341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of action of beta-blocking drugs in angina pectoris: a review.
    Robinson BF
    Postgrad Med J; 1976; 52 Suppl 4():43-5. PubMed ID: 9630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the combined effect of alpha-blocking and beta-blocking drugs on tolerance to exertion in patients with acute coronary insufficiency].
    Pavarani A; Volta G; Barbaresi F; Starcich R
    Folia Cardiol; 1969; 28(1):37-41. PubMed ID: 4391632
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris.
    Keyriläinen O; Uusitalo A
    Ann Clin Res; 1978 Aug; 10(4):185-90. PubMed ID: 30388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris.
    Jackson NC; Silke B; Verma SP; Reynolds G; Hafizullah M; Taylor SH
    Postgrad Med J; 1984; 60 Suppl 4():11-6. PubMed ID: 6527973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirect assessment of myocardial oxygen consumption in the evaluation of mechanisms and therapy of angina pectoris.
    Amsterdam EA; Hughes JL; DeMaria AN; Zelis R; Mason DT
    Am J Cardiol; 1974 May; 33(6):737-43. PubMed ID: 4151042
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamic effects of practolol at rest and during exercise.
    Leon DF; Thompson ME; Shaver JA; McDonald RH
    Circulation; 1972 Jan; 45(1):46-54. PubMed ID: 4399771
    [No Abstract]   [Full Text] [Related]  

  • 14. Alpha- and beta-blockade in angina pectoris.
    Taylor SH
    Drugs; 1984; 28 Suppl 2():69-87. PubMed ID: 6151892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alprenolol on central hemodynamics and exercise tolerance in patients with angina pectoris.
    Jonsson B; Olsson AG; Orö L
    Cardiology; 1973; 58(3):152-61. PubMed ID: 4149331
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
    Libretti A; Gregorini L; Valentini R
    Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical management of patients with angina. Has first-line management changed?
    Chatterjee K; Rouleau JL; Parmley WW
    JAMA; 1984 Sep; 252(9):1170-6. PubMed ID: 6147425
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of a new beta-blocker (CI 775) on left ventricular hemodynamics at rest and during exercise (author's transl)].
    Trieb G; Sigwart U
    Herz; 1978 Aug; 3(4):276-87. PubMed ID: 31326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta adrenergic blocking agents for exertional angina pectoris.
    Thadani U
    Herz; 1982 Jun; 7(3):179-87. PubMed ID: 6124493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effects.
    Frishman W; Silverman R
    Am Heart J; 1979 Jun; 97(6):797-807. PubMed ID: 34990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.